Dr. Bruno Bockorny, MD
Claim this profileBeth Israel Deaconess Medical Center
Studies Pancreatic Cancer
Studies Squamous Cell Carcinoma
6 reported clinical trials
14 drugs studied
Area of expertise
1Pancreatic Cancer
Stage IV
Stage III
ALK positive
2Squamous Cell Carcinoma
Stage IV
ALK positive
EGFR positive
Affiliated Hospitals
Clinical Trials Bruno Bockorny, MD is currently running
SGN-EGFRd2
for Advanced Cancer
This study will test the safety of a drug called PF-08046052/SGN-EGFRd2 in participants with advanced solid tumors. It will also study the side effects of this drug. A side effect is anything a drug does to the body besides treating the disease. Participants will have cancer that cannot be removed (unresectable) or has spread through the body (metastatic). This study will have three parts. Parts A and B of the study will find out how much PF-08046052/SGN-EGFRd2 should be given to participants. Part C will use the dose found in parts A and B to find out how safe PF-08046052/SGN-EGFRd2 is and if it works to treat solid tumor cancers.
Recruiting1 award Phase 13 criteria
SGN-B6A
for Cancer
This trial is testing a new drug called sigvotatug vedotin alone and with other treatments to see if it is safe and effective for people with solid tumors. It will also check for any side effects. The study includes different parts to determine the best dose and to see how well the drug works alone and in combination with other treatments.
Recruiting1 award Phase 1
More about Bruno Bockorny, MD
Clinical Trial Related5 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Bruno Bockorny, MD has experience with
- Pembrolizumab
- AGEN1423
- Balstilimab
- Gemcitabine
- Nab-paclitaxel
- Anti-PD-(L)1 Antibody Therapy
Breakdown of trials Bruno Bockorny, MD has run
Pancreatic Cancer
Squamous Cell Carcinoma
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Bruno Bockorny, MD specialize in?
Bruno Bockorny, MD focuses on Pancreatic Cancer and Squamous Cell Carcinoma. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are Stage III.
Is Bruno Bockorny, MD currently recruiting for clinical trials?
Yes, Bruno Bockorny, MD is currently recruiting for 2 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Bruno Bockorny, MD has studied deeply?
Yes, Bruno Bockorny, MD has studied treatments such as Pembrolizumab, AGEN1423, Balstilimab.
What is the best way to schedule an appointment with Bruno Bockorny, MD?
Apply for one of the trials that Bruno Bockorny, MD is conducting.
What is the office address of Bruno Bockorny, MD?
The office of Bruno Bockorny, MD is located at: Beth Israel Deaconess Medical Center, Boston, Massachusetts 02155 United States. This is the address for their practice at the Beth Israel Deaconess Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.